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iProblem Description
When ultrasound is absorbed and scattered in an object, a radiation force is gen-
erated on the object. This force has a similar effect on material transport as a
pressure gradient.
The task is to theoretically and experimentally explore the effect of such a radia-
tion force in order to enhance the transport of chemotherapeutic drugs from the
capillaries and through the extracellular matrix (ECM) (Interstitium) in cancer
tumors. The drug can appear in free molecular form or encapsulated in nanoparti-
cles. Experimental studies are conducted in a prostate cancer model in mice. The
candidate should explore options for ultrasound equipment which can be used
for in vivo experiments. The generated ultrasound radiation force should also be
explored theoretically by use of existing simulation tools. Simulations should be
used in order to decide an efficient scanning strategy which generates large forces
without heat generation in the tissue.
Experiments in mice are conducted in cooperation with Professor Catharina de-
Lange Davies’ group at the Department of Physics.
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Abstract
Cancer is today one of the leading causes of death world wide. Chemotherapy is a
cancer treatment where cytotoxic drugs are administered intravenously in order to
kill the cancer cells. This is a therapy form which is widely used, although it has
large side effects and thereby greatly reduces the quality of life for the patients.
Some of the main challenges with chemotherapy is that a large fraction of the
dose is distributed in healthy tissue, and that the drug does not reach all cells
in the tumor. Ultrasound waves generate a radiation force on the medium they
propagate through. This force acts similar to a pressure gradient and can enhance
transport of macromolecules from the capillaries and through the extracellular
matrix (ECM) in tumors. By encapsulating the drug in larger particles, one can
limit the concentration of drugs in healthy tissue, while ultrasound radiation force
can enhance the concentration in the tumor. An in vivo experiment to investi-
gate this effect was planned and conducted. Simulations of ultrasound waves that
propagate through water and tissue show that appropriate ultrasound transducers
can generate large radiation forces and potentially increase transport from capil-
laries to central regions of solid tumors significantly. However, the results from
the conducted in vivo experiment must be analysed before any conclusions can be
drawn. These results were not available during writing.

vSammendrag
Kreft er i dag en av de vanligste døds˚arsakene i verden. Kjemoterapi er en form
for kreftbehandling hvor cytotoksiske medikamenter gis intravenøst for a˚ drepe
kreftceller. Dette er en terapiform som er mye brukt, til tross for at den har store
bivirkninger og dermed i stor grad reduserer livskvaliteten til pasientene. Noen
av hovedutfordringene med kjemoterapi er at store deler av medikamentdosen
havner i friskt vev, og at medikamentet ikke n˚ar frem til alle cellene i svulsten.
Ultralydbølger genererer en str˚alingskraft p˚a det mediet de forplantes gjennom.
Denne kraften virker tilsvarende som en trykkgradient og kan øke transporten av
makromolekyler fra kapillærer og gjennom den ekstracellulære matrise (ECM) i
svulster. Ved a˚ innkapsle medikamentene i større partikler, kan man begrense
konsentrasjonen av medikamentene i friskt vev, mens ultralyd str˚alingskraft kan
øke konsentrasjonen i svulsten. Et in vivo eksperiment for a˚ undersøke denne ef-
fekten ble planlagt og gjennomført. Simuleringer av ultralydbølger som forplanter
seg gjennom vann og vev viser at egnede ultralydtransducere kan generere store
str˚alingskrefter og potensielt øke transporten fra kapillærene til sentrale omr˚ader
av faste svulster. Men, før noen konklusjoner kan trekkes, ma˚ resultatene fra det
gjennomførte in vivo eksperimentet analyseres. Disse resultatene var ikke tilgjen-
gelige da dette ble skrevet.
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Chapter 1
Introduction
Cancer is today the leading cause of death in economically developed countries
and the second leading cause of death in developing countries[1]. Although cancer
treatment has improved in recent years, the mortality rates remain high, especially
for certain cancer sites, like the pancreas. Cancer-causing behaviours like smoking
and a fatty diet, in combination with an ageing population, cause the cancer
incident rates to continuously increase.
1.1 Motivation
Cancer is commonly treated with surgery, radiation therapy and chemotherapy, al-
though the range of treatment types has expanded greatly during the past decades.
A combination of two or more of these treatment types is often used. Surgery is
for example often followed by chemotherapy in order to ensure that no cancer cells
remain in the body. Chemotherapy treatment has two purposes; it shall prevent
cancer cell proliferation, have a cytostatic effect, and kill the cancer cells, have a
cytotoxic effect. The aim is to achieve this with minimal side effects. The effective-
ness of a drug is indicated by its therapeutic index, which is the ratio between the
maximum tolerated dose which can be delivered to the body, and the minimum
1
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effective dose which is needed in order to gain a therapeutic effect. Chemothera-
peutic drugs have very low therapeutic indices; the minimal effective dose can in
some cases be lethal.
Chemotherapeutic drugs are administrated intravenously in molecular form. The
small molecular sizes enable the drugs to leave the blood flow through the capil-
laries in both healthy and cancerous tissue. This implies that in order to ensure
that a minimal effective dose is delivered at the tumor site, the rest of the body is
exposed to a corresponding dose. The side effects of the chemotherapy treatment
greatly reduce the quality of life for cancer patients. Researchers therefore aim
to allow chemotherapeutic drugs to be delivered and absorbed locally, in order to
minimize the side effects of the therapy and increase the patients’ quality of life.
This thesis presents opportunities for cancer treatment using a combination of
ultrasound and chemotherapeutic drugs, and presents an overview of a conducted
in vivo experiment where this was tested in mice. The idea is to encapsulate
the chemotherapeutic agent in drug carriers with diameter of approximately 3 to
100 nm. Such nanoparticles (NPs) are too large to penetrate the capillary walls in
healthy tissue, and will therefore reduce the side effects of the therapy, as only a
limited amount of the drug will reach other areas than the tumor. Capillary walls
in tumor tissue have larger intracellular spaces than capillaries in healthy tissue,
which enable the large drug carriers to extravasate into the tumor interstitium. In
this way, the chemotherapeutic treatment will be local, and the therapeutic index
will increase. There are, however, many challenges associated with this approach.
Transport of macromolecules across the capillaries in tumor tissue is slow due
to elevated pressure in the tumor interstitium. Many tumors have necrotic and
hypoxic areas, and the vascular density is strongly heterogeneous. In order to
enhance the transport across the vessel walls and to deliver the drug also to areas
with low vascular density, the idea is to apply ultrasound.
Ultrasound waves are sound waves with frequencies above the hearing range, i.e.
larger than 20 kHz. The waves are longitudinal, mechanical waves which require
a medium in order to propagate. As ultrasound waves propagate through tissue,
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the tissue is alternately compressed and expanded. In this process, some of the
energy of the wave is lost to scattering and absorption. Change in the momentum
of the wave generates a net force in the propagation direction. This force is called
the ultrasound or acoustic radiation force, and has in recent years been studied
as a mean to enhance transport of drugs across the capillary walls in solid tumors
[2].
1.2 Structure of the thesis
Encapsulating chemotherapy in nanoparticles in combination with application of
ultrasound is an approach towards targeted drug delivery, in order to increase
the therapeutic index of chemotherapy. In vitro experiments have shown that
ultrasound radiation force is able to create streaming of particles towards the
vessel walls in areas of high flow [3]. Also in vivo experiments show promising
results in local delivery of cytotoxic drugs to tumors [2]. However, thorough in
vivo verification is needed before this concept can be introduced to the clinic. This
thesis aims to introduce the reader to the concept of ultrasound mediated drug
delivery and how this can be verified in an in vivo experiment in mice. The thesis
is structured in the following manner:
• Chapter 2 presents a theoretical background of tumor biology and ultra-
sound physics.
• Chapter 3 presents key factors and parameters to consider when designing
an experiment to investigate the effects of ultrasound on delivery of nanopar-
ticles to tumors in mice.
• Chapter 4 presents simulations of ultrasound wave propagation and gener-
ated radiation force, in order to choose the appropriate ultrasound equipment
and decide on a physical set-up.
• Chapter 5 presents the conducted in vivo experiment.
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• Chapter 6 discusses an experimental set-up with respect to the simulated
wave fields and the conducted in vivo experiment.
• Chapter 7 presents conclusive remarks and outlines further work in the
field of ultrasound mediated drug delivery.
Due to considerable delays in the delivery of transducers for the in vivo experiment,
the results from the experiment are not yet analysed and will not be presented
in this thesis. The focus is therefore rather on how one can design a similar
experiment of high quality for further investigation of these phenomena in the
future.
Chapter 2
Background: Cancer biology and
ultrasound physics
In order to understand the concept of ultrasound mediated drug delivery (UMDD),
the reader will be introduced to some of the biological properties of cancerous tissue
and physical properties of ultrasound wave propagation.
2.1 Tumor growth
Tumors are results of cell mutations which induce rapid cell division. A cancerous
tumor starts with one mutated cell which proliferates abnormally. The resulting
two cells in turn proliferate into four cancerous cells, leading to an exponential
growth rate. This rapid cell division and growth requires increased supply of
oxygen and nutrition, which serves the need for vascular recruitment.
Two genes are especially important in tumor development and growth: the proto-
oncogenes, and the tumor suppressor genes [4]. Proto-oncogenes are genes which
encode proteins that are involved in the regulation of cell growth and prolifera-
tion, while tumor suppressor genes encode proteins that in some way inhibit cell
proliferation. Mutations in these genes are common initiators to cancer.
5
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Mutations in the proto-oncogenes lead to overstimulation of the growth promoting
machinery in the cell. Growth factor receptors attached to the surface of the
cell normally fire a growth signal to the cell nuclei when stimulated by a growth
factor released from a neighbouring cell. In a similar manner, inhibitory brigades
attached to the cell surface react to growth blocking signals and fire an inhibitory
signal when stimulated. Mutations in the gene expressions enable the growth
factor receptors to fire even though they are not stimulated from the outside, and
inhibitory brigades to ignore growth blocking signals from neighbouring cells [5].
In many types of cancer cells, critical components of these brigades are inactive
or absent.
It is the cell cycle clock that receives the growth promoting and inhibitory signals.
Based on the received signal, the cell cycle clock decides whether the cell should
move on in its life cycle or not. The clock is often deranged in cancer cells. This,
in combination with bombardments of growth factors and limited signals from
growth inhibitors, leads to rapid cell growth and division.
2.1.1 Tumor vasculature
As the tumor grows, the need for oxygen and nutrition increases. This causes tu-
mor angiogenesis, the process of growth and formation of new blood vessels based
on signals and actions induced by the tumor and the tumor microenvironment
[6]. Tumor angiogenesis is one of the six hallmarks of cancer; it is an indica-
tion of malignant development of a tumor [7]. In order to recruit and grow new
vasculature, vascular endothelial growth factors (VEGFs) are essential, and over-
expressed in most tumor types [6]. VEGFs are glycoproteins which induce both
vascular permeability and endothelial cell proliferation [8, 9]. Endothelial cells
are cells which form the endothelium, the interior surface of blood vessels. These
cells have VEGF receptors which react when stimulated by VEGFs, leading to a
series of events which result in blood vessel formation [6]. In addition, VEGFs can
increase the vascular permeability, allowing leakage of plasma proteins from the
blood vessels and formation of an extra-vascular matrix. This further enhances the
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environment for endothelial cell growth, as the extra-vascular matrix scaffolds the
cells and formation of new vessels. An over-expression of VEGFs will therefore
lead to rapid formation of new vasculature. VEGFs are among others released
from tumor cells which are oxygen-deprived.
Blood supply in healthy tissue is ensured by a structured and efficient vascular
network, with an hierarchic architecture. The main arteries are parallel to the
main veins, with intermediate arterioles, capillaries and venules. In contrast to
this, tumor vasculature is chaotic. Since tumor angiogenesis is a result of uncon-
trolled release of VEGFs, the resulting vasculature is highly tortuous. There is
no conventional hierarchy structure, and this lack of structure makes distinction
of capillaries, arterioles and venules hard. The resulting blood flow is difficult
to predict. Loops and tortuous formations also increase the vessels’ resistance to
blood flow.
In addition to total lack of vascular structure, tumor vasculature is characterized
by altered structure of the vessel walls. Due to the increased release of VEGFs, the
endothelial cell proliferation is also increased. Healthy vascular structures include
perivascular cells and protein complexes that cover the endothelial cell layer and
stabilize the vessel. This coverage lacks in tumor vasculature, resulting in large
intercellular spaces and leaky vessel walls [6]. There are larger gaps between
the endothelial cells, which allow for transport of macromolecules through the
fenestrae of the vessel wall. The altered structure also leads to leakage of blood
plasma into the interstitium, which results in an elevated interstitial fluid pressure
(IFP). Tumors often have limited lymphatic drainage, which also contributes to
increased IFP. Increased IFP can cause occlusion of the vessels and thereby lead
to hypoxia, which results in persistent release of VEGFs.
In healthy tissue, transport of macromolecules across the capillary walls is nor-
mally governed by convection and diffusion. Diffusion is mass transport driven
by the concentration gradient, while convection is mass transport driven by the
pressure gradient. The capillary blood pressure is larger than the pressure in the
surrounding tissue, which creates a pressure gradient from the vessels and into the
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interstitium. The increased IFP in tumors eliminates this gradient partly or fully.
This makes transport across the vessel walls slow in tumor tissue, as diffusion is
the only transport initiating mechanism. Tumor blood flow is not laminar, but
rather turbulent. Molecules may therefore also circulate within the center of the
blood stream, without reaching the vessel wall and be able to extravasate into the
surrounding tissue.
2.1.2 The Enhanced Permeability and Retention Effect
In tumor tissue, leaky vasculature enables macromolecules to travel across the
capillary walls, while altered lymphatic drainage enables them to remain and ac-
cumulate there [10]. This is recognized as the enhanced permeability and retention
(EPR) effect . Possibilities for selective intervention and drug targeting based on
the EPR effect have been studied as a new approach towards local tumor treat-
ment [11, 12]. Nanosized macromolecules are, due to their size, able to escape
renal clearance. They are also too large to penetrate the capillary walls of healthy
tissue. Due to intercellular fenestrae in tumor vasculature, macromolecules can
leave the blood stream at the tumor site and get trapped in the tumor intersti-
tium. Altered lymphatic drainage leads to aggregation of these molecules over
time. This process is, however, slow, because the high IFP decreases the pressure
gradient in tumors, as described in the previous section.
2.1.3 Extracellular Matrix
The tumor cells are connected by the extracellular matrix (ECM), which is a com-
plex network of biochemical components. These include proteins, glycoproteins,
proteglycans and polysaccharides [13]. In healthy tissues, the ECM is structured,
and the network of components with different physical, biochemical and biome-
chanical properties is essential in regulating cell behaviour. The rigidity, porosity,
spatial alignment and orientation of the ECM components, all contribute to the
physical properties of scaffolding the surrounding tissue. At cancer sites, the
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structure of the ECM becomes disorganized, and it can be a contributor to cell
proliferation and metastasis [14].
In an UMDD perspective, the permeability of the ECM in tumors is of interest,
as it is desirable that drug loaded particles are able to penetrate the ECM by
application of an ultrasound pressure wave. It is shown that the stiffness of the
ECM is correlated with the total tissue content of collagen, and that tumor tissue
is more rigid than healthy tissue [15]. Large collagen content contributes to a lower
compliance, which makes the tissue more penetration-resistant to macromolecules
than normal tissue [16]. Collagen fibres can also physically hinder the transport
of a particle through the ECM, if the particle is larger than the spacing between
the fibres.
It is also of interest whether cancerous ECM has thixotropic properties or not.
Thixotropic fluids are fluids which are thick under static conditions, and become
less viscous when stirred. If this is the case for tumor ECM, an external force
above a certain threshold is required to be able to move particles within the ECM.
However, when particle movement is initiated, the ECM will be less viscous, which
enables a smaller force to keep the particle moving. If the ECM does not possess
this property, a smaller external force applied over a longer time will have the
same effect, and it will then be the total force impulse which determines the
length of the particle movement. Basement membranes are extra-cellular matrices
surrounding endothelial and epithelial cells, for example extra-vascular matrices.
In general, basement membranes hold thixotropic properties [17], but since the
ECM structure and composition is altered in tumors, it is not known whether this
property is valid for tumor basement membranes and tumor ECM.
2.2 Ultrasound Physics
Ultrasound waves are sound waves with frequencies above the hearing range, i.e.
above 20 kHz. The waves are longitudinal, mechanical waves which require a
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medium in order to propagate. For medical applications, ultrasound with frequen-
cies in the range of 1− 50 MHz is normally used. Ultrasound in medicine is used
as a diagnostic imaging method or for treatment purposes.
As ultrasonic waves propagate in tissue, the tissue is alternately compressed and
expanded as the energy alternates between kinetic and potential energy states.
Inhomogeneities in the tissue lead to energy absorption and scattering of the wave.
These two factors reduce the amplitude of the wave as it propagates deeper into
tissue.
2.2.1 Linear propagation
In order to model wave propagation in a medium, equations which describe the
interactions between the pressure wave and the medium it propagates through are
needed. We assume that the pressure wave acts on a volume V . The vibrations in
the wave motion can be described by the displacement, ~Ψ(~r, t), of a particle from
its equilibrium position ~r. If we choose a volume V = ∆V so small that ∇~Ψ is
approximately constant over the volume, we can approximate the volume change
by
∂V = ∇~Ψ(~r, t)∆V (2.1)
This is illustrated in figure 2.1. Hence, the relative volume change is
∂V
∆V
= ∇~Ψ (2.2)
If now a linear, non-viscous relationship between the pressure and volume com-
pression is assumed, this can be described by
p = −1
κ
∂V
∆V
= −1
κ
∇~Ψ ∂p
∂t
= −1
κ
∇~u (2.3)
where ~u is the particle velocity and κ is the compressibility of the medium[18].
The conservation equation for momentum in Lagrange variables can be written
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∆z
[ψ(z,t) + ∆z∂ψ/∂r]
p(r,t)
ψ(r,t)
I1 I2
p(r,t) + ∆z∂p/∂r
Figure 2.1: Volume change of a small element caused by wave motion
ρ
∂~u(~r, t)
∂t
= −∇p(~r, t) (2.4)
where it is assumed that no other forces are acting on the tissue than those caused
by the compression of the tissue from the wave itself. However, the wave needs to
be generated by external forces acting on the tissue. We therefore add an extra
force ~f per unit volume to the momentum equation
ρ
∂~u(~r, t)
∂t
= −∇p(~r, t) + ~f(~r, t) (2.5)
Applying the ∇-operator to this equation yields
ρ
∂∇~u(~r, t)
∂t
= −∇2p(~r, t) +∇~f(~r, t) (2.6)
Substitution of ~u(~r, t) from equation (2.3) gives us the wave equation i three di-
mensions
∇2p(~r, t)− ρκ∂
2p(~r, t)
∂t2
= ∇~f(~r, t) (2.7)
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If linear propagation is assumed, ultrasonic wave propagation can be described by
the inhomogeneous wave equation in its general form:
∇2p(~r, t)− 1
c2
∂2p(~r, t)
∂t2
= −s(~r, t) c =
√
1
ρκ
(2.8)
where p(~r, t) is the pressure amplitude, c =
√
1
ρκ
is the speed of sound in tissue,
and −s(~r, t) is a source term that can represent linear scattering.
Figure 2.2 shows an ultrasound pulse at focus generated by a linear simulation of
a 10 MHz ultrasound pulse. The parameters used in the simulation are given in
table 2.1.
Table 2.1: Simulation parameters for linear simulation
Simulation parameters
Center frequency 10 MHz
Aperture Circular
Aperture width 19 mm
Pulse length 0.5 µs
Focus 50 mm
Water propagation 40 mm
Initial pressure 200 kPa
The propagation equation does not involve any quadratic or higher order terms,
which implies that the frequency components will not change as the wave prop-
agates. This can clearly be seen from the frequency spectrum in figure 2.2, as
all the energy is situated around the center frequency, and the pulse form is not
distorted.
2.2.2 Non-linear propagation
Human tissue does also have non-linear properties, that is, the compressibility, κ,
and the density, ρ, change with applied pressure. In order to govern a non-linear
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Figure 2.2: A 10 MHz pulse at focus in 50 mm simulated with linear propaga-
tion through water and soft tissue.
wave equation, we introduce the tissue density, ρ(~r), and compressibility, κ(~r),
at the equilibrium position, ~r. A material relation which accounts for non-linear
elasticity and linear loss is given by [19]:
−∇ · ~Ψ(~r, t) = κ(~r)ρ(~r)− βn(κ(~r)p(~r, t))2 − κ(~r)Lp(~r, t) (2.9)
where βn is the coefficient of non-linearity and L is a convolution kernel accounting
for frequency dependent absorption. Combining this with the relation
~u =
∂~Ψ
∂t
(2.10)
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and equation (2.4) yields a generalized Westerwelt equation for non-linear propa-
gation in tissue [19, 20]:
κ
∂2p
∂t2
−∇ · (1
ρ
∇p) = ∂
2
∂t2
(βnκ
2p2 + κLp) (2.11)
The non-linearity-term
∂2
∂t2
βnκ
2p2 (2.12)
introduces a pressure dependent pulse form distortion. When the tissue is com-
pressed, the compressibility decreases, in turn causing the speed of sound to in-
crease due to the relation c = 1√
ρκ
. This results in faster propagation of the wave
peaks than the wave troughs, causing a saw-tooth waveform as the wave propa-
gates. This non-linear waveform distortion transfers energy from the fundamental
band to higher harmonic components.
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Figure 2.3: A 10 MHz pulse at focus in 50 mm simulated with non-linear
propagation through water and soft tissue.
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Figure 2.3 shows a 10 MHz ultrasound pulse at focus generated by a non-linear
simulation [21]. The parameters in this simulation are the same as the parameters
in the linear simulation (see table 2.1) shown in figure 2.2. From the non-linear
simulation we can clearly see the distortion of the pulse, both from the time
and frequency domain plots. The pulse form has sharp peaks, and the energy is
pumped into harmonic and sub-harmonic components. The distorted waveform
appears in focus due to higher harmonic components which are out of phase.
An important aspect is that both the non-linear and linear simulations shown are
generated by simulating propagation through water before the wave reaches tissue.
Water is a material with almost no attenuation, that is, the higher frequency
components are not absorbed, and energy will continue to be pumped into higher
harmonics. Soft tissue in the body is however attenuating, and both the amplitude
and the frequency components will to a large extent be reduced. This is illustrated
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Figure 2.4: A 10 MHz pulse at focus in 50 mm simulated with non-linear
propagation through 50 mm soft tissue. The rest of the simulation parameters
are similar to the parameters listed in table 2.1.
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in figure 2.4. From this simulation one can clearly see that almost all the energy in
the wave is attenuated. Even though the beam is focused, the pressure in focus is
very low and only the second harmonic is barely present in the frequency spectrum.
The higher harmonic components are attenuated, and the resulting waveform is
very close to a sinusoid.
2.2.3 Focusing and diffraction of beams
Ultrasound beams can either be focused or unfocused, depending on the curvature
of the transducer surface. If the transducer surface is flat, the beam will be
unfocused. If the transducer surface is curved with a radius r, the focal point will
lay in the point which has the distance r to all points on the transducer surface.
The area around the focal point is called the focal zone. In this area, the pressure
amplitudes will add constructively and create the largest pressures and intensities
in the sound field. The size of the focal zone is dependent both on the F-number,
F#, and the frequency. The F-number is the relation between the focus depth, zf ,
and the aperture size, D, of the transducer
F# =
zf
D
(2.13)
and is used as a relative measurement of how focused the transducer is. The lower
F-number, the more focused is the beam and vice versa. The −3 dB length and
width of the focal zone is approximated by [18]
Df ≈ F#λ = z
D
λ and Lf ≈ 4λF 2# (2.14)
The beam form of a focused beam is illustrated in figure 2.5. The wavefront is
approximately planar in the focal zone. Focusing can also be achieved by a focusing
lens, which can be attached to a flat transducer surface. Such an acoustic lens
bends the sound waves in a similar manner as an optical lens bends light beams.
When an ultrasound wave is emitted from the transducer surface, it will be
diffracted in the same way as light passing through a small opening. This is
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Figure 2.5: Illustration of transducer focusing.
due to the fact that the wave does not origin from a single point, but rather from
many points along the surface of the piezoelectric element. The resulting sound
field therefore consists of waves which interact and interfere with each other. At
every point where the waves interact, the resulting amplitude of the particle dis-
placement is the sum of the amplitudes of the interacting waves. If the waves are
in phase, the result will be a larger amplitude. However, if the waves are out of
phase, they will destructively interfere and cancel each other out. This diffraction
pattern thus produces areas with larger amplitudes, but also areas of destructive
interference and zero-points in the nearfield. In the focal zone, the waves sum up
to one constructive interference field, which generates the largest pressure ampli-
tudes in the field. For therapeutic purposes, it is important that the region of
interest is not placed in any of the destructive interference zones.
2.2.4 Ultrasound Radiation Force
When an ultrasound wave propagates through tissue, it produces a net force on
the volume it acts on. This force is called the ultrasound radiation force (URF)
and is a result of transfer of momentum from the sound wave in an attenuating
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medium where the pressure and particle velocity become out of phase [22]. In
order to mathematically model this force, continuum mechanics is useful.
Stress expresses the internal forces that neighbouring particles exert on each other
in a continuous material. When a liquid is under pressure, each particle is pushed
inwards by the surrounding particles, and, in reaction, pushes the surrounding
particles outwards. At ultrasonic frequencies, soft tissues can be modelled as
viscous fluids [23] and stress then represents the force per unit area that counteracts
the applied external force. In terms of Cauchy’s stress tensor, ~σ, Newton’s second
law can be expressed by the Euler description as
fi =
∂σij
∂xj
= ρai (2.15)
or in its invariant form
~F = ∇~σ = ρ~a (2.16)
where ~F is the externally applied force per unit volume and ~a is particle acceler-
ation [24, pp. 134-136]
For a linearly viscous (Newtonian) fluid, the constitutive equation can be described
by
σij = −pδij +
(
k − 2
3
µf
)
Dkkδij + 2µfDij (2.17)
where Dij =
1
2
(
∂ui
∂xj
+
∂uj
∂xi
)
represents the rate of deformation, ~u the particle ve-
locity and p is a scalar pressure. k and µf are material constants, representing
bulk and shear viscosity, respectively.
Acceleration of a fluid particle is the sum of the local particle acceleration and the
convection [25, pp. 128-130]:
~a =
∂~u
∂t
+ (~u · ∇) ~u (2.18)
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By combination of equations (2.15) and (2.18), the Navier-Stokes equation of mo-
tion is obtained. For a linearly viscous fluid, described by equation (2.17), Navier-
Stokes equation reduces to
−∇p+
(
k +
µf
3
)
∇ (∇ · ~u) + µf∇2~u = ρ
(
∂u
∂t
+ (~u · ∇) ~u
)
(2.19)
The solution to this equation can be approximated by a perturbation analysis [26,
Perturbation methods, Jerry H. Ginsberg, pp. 279-308]. This involves expanding
the density, pressure and velocity in terms of time-dependent approximations to
the steady-state solutions, with higher-order time-independent correction terms.
If terms up to second-order are kept, and the analysis is applied to the right-hand
side of equation (2.19), the approximation leads to
ρ0
∂~u2
∂t
+
∂ρ1~u1
∂t
+ ρ0 (~u1∇ · ~u1 + ~u1 · ∇~u1) (2.20)
where ρ0 is the material density at equilibrium, ~u1 and ρ1 are first order approxi-
mations for particle velocity and density, and ~u2 is a higher-order correction term
representing the acoustic streaming velocity. This force represents the transfer of
momentum from the wave to the attenuating material. If the temporal average
of this expression is calculated, the first two terms will be zero, and the resulting
equation reduces to:
~F = 2ρ〈~u~u,z 〉 (2.21)
where the force is in the direction of the propagating wave, the z-direction. If
exponential attenuation is assumed, the radiation force per unit volume can be
expressed as
~F =
σe(ω)~I(ω)
c
(2.22)
where σe is the acoustic intensity extinction cross section, I(ω) is the acoustic
intensity and c the speed of sound in tissue. ω = 2pif is the angular frequency
of the incident wave. The extinction cross section of the acoustic intensity is the
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sum of the scattering and absorbing cross sections
σe(ω) = σs(ω) + σa(ω) = 2α(ω) (2.23)
and is twice the pressure extinction cross section, α(ω). Scattering is the re-
direction of incident acoustic energy from the incident beam, while absorption is
the conversion of acoustic energy into thermal energy. Note that the tissue in the
above equations is considered a continuum, rather than discrete particles. This is
an approximation, since tissue is strongly heterogeneous with gaps between neigh-
bouring cells and interconnecting ECM. We have also assumed that the wavefront
is planar. As described in section 2.2.3, this is a valid assumption in the focal
zone.
Radiation force can also be described in a more intuitive way. This is illustrated
in figure 2.6. If a wave is propagating in an attenuating medium, one can look at
∆Z
I + ∆IIc c
Figure 2.6: Illustration of generation of URF.
the propagation through a volume with size ∆z in the propagating direction. The
moment of the wave that enters the volume is then
ρu2i =
ρc
c
u2i =
Z0
c
u2i =
I
c
(2.24)
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where Z0 = ρc is the characteristic acoustic impedance of the medium. The
intensity is reduced by scattering and absorption within the volume element, and
the moment of the wave which exits the volume is then
ρu2o =
I + ∆I
c
(2.25)
where the intensity lost in the volume is
∆I = −σe(ω)I(ω) (2.26)
The change in moment per unit volume is force per unit volume, and hence the
ultrasound radiation force can be expressed as
∆~F =
(
I(ω)
c
− I(ω) + ∆I(ω)
c
)
∆V =
σe(ω)I(ω)
c
∆V (2.27)
This is a similar expression to equation (2.22) derived by continuum mechanics.
A pressure p(~r, t) acting on a surface S of a volume V produces a net force on the
volume given by
~F = −
∫
S
d2r~np(~r, t) = −
∫
V
d3r∇p(~r, t) (2.28)
where ~n is the outward unit normal to the surface [27]. For a small volume ∆V ,
the integral can be approximated to
∆~F = −∇p(~r, t)∆V (2.29)
When comparing this to equation (2.27), it can be seen that the radiation force
has the similar form as a pressure gradient acting on a volume. As mentioned
in section 2.1.2, the elevated interstitial fluid pressure in tumors decreases the
pressure gradient which normally contributes to macromolecule transport across
the capillary wall. UMDD is based upon the idea that URF can act similar to
such a pressure gradient and thereby force drug loaded macromolecules across the
tumor capillary walls and into the interstitium.
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The intensity extinction cross section is dependent upon the frequency, and is
generally larger for larger frequencies. Since a nonlinear simulation will generate
higher harmonic and sub-harmonic frequencies, it is important to include this in
the calculation and simulation of ultrasound radiation force. Another important
aspect is that higher frequencies generate a narrower focal zone and thereby higher
pressures and intensities, which in turn also contribute to higher radiation force
output.
Pressures in the body are normally measured in mmHg. The radiation force is a
force per unit volume, i.e. N/m3. These units relate in the following manner:
1 mmHg ∼ ρHggh = 13.546 ·103 N
m3
·9.81 m
s2
·10−3m = 132.9 N
m2
= 132.9 Pa (2.30)
This means that a radiation force per unit volume corresponds to
1
N
m3
=
1
132.9
mmHg
m
= 7.524 · 10−3mmHg
mm
(2.31)
2.2.5 Ultrasound Tissue Heating
As described in the previous section, a part of the wave intensity is attenuated as
the wave propagates through tissue. Along a line in the z-direction, the change
can be described as
dI = −σe(ω)I(ω)dz (2.32)
If we assume plane wave propagation, the relation between the pressure and in-
tensity is
I =
P 2
2Z0
(2.33)
where Z0 is the acoustic impedance of the medium. The change in intensity can
therefore be described as
dI =
d
dP
(
P 2
2Z0
)
=
PdP
Z0
= −σe P
2
2Z0
dz (2.34)
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Which gives the relation
dP = −σe(ω)
2
Pdz (2.35)
At a point z, the intensity and pressure can be expressed as
I(z, ω) = I0e
−σe(ω)z P (z, ω) = P0e
−σe(ω)
2
z (2.36)
As described in equation (2.23), σe(ω) = 2α(ω), where α(ω) is the amplitude at-
tenuation coefficient, which is the sum of the amplitude scattering and absorption
coefficients, α = αa + αs [28]. In tissue a typical value is α = 0.5 dB/cmMHz [18].
Only the absorption contributes to heat generation. If the tissue has an absorp-
tion coefficient αa, the generated heat per unit volume [W/m
3] can be found by
differentiation of equation (2.36) as
~qv = −d
~I(z)
dz
= 2αa ~I(z) (2.37)
Penne’s bio-heat equation models the heat distribution in tissue [29, 30] as
ρC
∂T
∂t
= k∇2T −WbCbT + q (2.38)
where ρ is tissue density, C is the specific heat of the tissue, k is the thermal
conductivity and T is the temperature. The term WbCbT accounts for blood
perfusion, where Wb is the perfusion rate and Cb the specific heat of blood. q is
the heat generated in tissue. Since the heat generated in the tissue by metabolic
activity is much lower than that generated by the ultrasound absorption, it can
be ignored, i.e. q ≈ qv.
Tissue heating is a safety issue in medical ultrasound applications. High inten-
sity focused ultrasound (HIFU) treatment utilizes the generated heat from high
intensity beams to ablate pathological tissue at temperatures around 60 ◦C. In ul-
trasound imaging applications, tissue heating is strictly regulated. Hyperthermia
is considered to be any temperature above 40 ◦C, and temperatures above 45 ◦C
alters the tertiary structure of proteins and is lethal to most organs and organisms
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[31]. The American Food and Drug Administration (FDA), limits the acoustic
output from commercial imaging transducers to 720 mW/cm2, which corresponds
to a temperature rise of maximum 2 ◦C in tissue [32].
2.3 Ultrasound Transducer Properties
Commercial ultrasound transducers are normally built up by a stack of piezo-
electric ceramic layers with backing and matching layers in back and front of the
piezoelectric elements. The characteristics of the chosen ultrasound transducer
are of high importance when considering an ultrasound mediated drug delivery
scheme. In order to get the desired output, the transducer needs to be optimized
for the desired purpose.
2.3.1 Bandwidth and efficiency
Transducer bandwidth is the range of the frequency band where the transducer
operates within −3 dB of the output at the fundamental frequency. Imaging trans-
ducers normally have larger bandwidths than therapy transducers. This is due to
the fact that bandwidth and efficiency is closely connected. In order to obtain
larger bandwidths, the piezoelectric elements are sliced in smaller elements, and
the spacing between them is filled with a viscoelastic material. Backing and match-
ing layers are also viscoelastic, and these layers introduce losses. Larger bandwidth
leads to larger losses in the transducer, which again cause transducer self-heating.
For imaging purposes, a broad-band transducer provides opportunities for imag-
ing at different depths and with different resolutions. Therapy transducers should
however produce large outputs, and are dependent upon good efficiency. Efficiency
is defined as the ratio between the transmitted acoustic energy and the applied
electric energy
η =
Wac
Wel
(2.39)
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For therapy purposes, the desired output should be as high as possible, which
implies that the losses in the transducer should be as small as possible. This is
easier achieved if the transducer operates in a narrow frequency band.
2.3.2 Self-heating and cooling
Transducer self-heating is an important aspect when creating a transducer for
treatment purposes. It is important not to burn the patient or the operator,
but it is also important not to burn and destroy the piezoelectric material and
thereby destroy the transducer. If layers of viscoelastic materials are used, these
materials can delaminate, and create layers of air inside the transducer. Air inside
the transducer will cause total reflections which again will destroy the transducer
elements. Some energy will always be transformed to heat as the piezoelectric
elements start to vibrate. One approach to reduce the self-heating is to reduce the
duty cycle. The duty cycle is the percentage of a period the signal is active, i.e.
the pulse length, Tp relative to the pulse repetition time Tr;
DC =
Tp
Tr
(2.40)
By reducing the duty cycle, the transducer will be inactive between each trans-
mitted pulse, which enables heat to dissipate.
2.3.3 Aperture size and shape
Transducers are available in all shapes and sizes, from single-element transducers
to matrix arrays with 3D imaging capabilities. In general, transducer apertures
are either circular or rectangular. Circular apertures normally consist of one or a
few elements, while rectangular transducers normally consist of arrays of smaller
elements. The transducer surface can also be flat or curved in order to create
focusing as discussed in section 2.2.3.
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Circular apertures must have the same focus in elevation and azimuth, while these
can be different for rectangular apertures. With regards to beam steering, rect-
angular arrays allow for electrical beam steering in azimuth, and sometimes also
in elevation, direction. In order to steer the beam in one direction, there must
be several small elements in that direction in the transducer. If one wants to
steer in two direction, a matrix array is needed. Electronic beam steering is fast
and easy, however, as mentioned in section 2.3.1, slicing of elements introduces
viscoelastic materials which lead to losses in the transducer. Circular apertures
cannot be steered electronically, they must be mechanically moved. For imaging
purposes, different types of rectangular arrays are widely used. For treatment
purposes, there is no definite truth about the best transducer aperture shape.
Off-the-shelf transducers designed for high-output purposes are, however, mostly
circular, single-element transducers. Another important consideration is the aper-
ture size and its focus. As both the focal length and width are dependent on the
F-number (see equation (2.14)), this ratio is crucial in order to design an efficient
UMDD scheme.
Chapter 3
Experiment design
There are several considerations that need to be done when designing an animal
experiment in order to investigate the effect of ultrasound on drug delivery from
nanoparticles to solid tumors. These considerations involve choosing an appropri-
ate transducer, design of an efficient scanning pattern and an efficient and accurate
physical set-up of the experiment.
3.1 Physical limitations
The transducer output is limited by the applied input voltage, Vtt and the trans-
ducer efficiency. The applied input voltage is in turn limited by the available
voltage generator and amplifier. In order to generate a high intensity output, one
is therefore dependent upon a voltage generator and amplifier which enable the
maximum input the transducer can handle.
The average electrical input power delivered to the transducer is
Pel = V
2
tt,rms Re
{
1
Zel
}
DC (3.1)
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where Zel is the internal electrical impedance in the transducer and DC the duty
cycle. Vtt,rms is the average input voltage;
Vtt,rms =
√
2
2
Vtt (3.2)
The real part of the admittance, Re{ 1
Zel
}, can be written as
Re
{
1
Zel
}
= Re
{
Z∗el
ZelZ∗el
}
=
|Zel|cos(φ)
|Zel|2 =
cos(φ)
|Zel| (3.3)
where φ is the impedance phase angle. By combination of equations (3.1)-(3.3),
the electrical input power can be expressed as
Pel =
√
2V 2ttcos(φ)
2|Zel| ·DC (3.4)
The electrical impedance can easily be measured by an impedancemeter, when
frequency-dependent impedance curves are not provided by the transducer man-
ufacturer. Most manufacturers recommend the electrical input power to be lower
than a certain threshold, in order not to destroy the transducer by self-heating.
For example, Olympus recommends that the average power dissipation to their
immersion transducers should not exceed 125 mW [33]. When such a limit is pro-
vided, one can choose an available input voltage, and then calculate the maximum
duty cycle as
DCmax =
2|Zel|Pel,max√
2V 2ttcos(φ)
(3.5)
It is important to recognize that some parameters are bounded by the transducer
choice, while others are possible to adjust. The ideal transducer has high effi-
ciency, generates high pressures and tolerates large duty cycles. The duty cycle
is important as the desired output not only is a large radiation force, but also a
large impulse. This is illustrated in figure 3.1.
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Figure 3.1: Transducer parameters governing output for radiation force and
impulse.
3.2 Scanning strategy
In addition to determine the maximal output power and duty cycle, the transducer
determines the beam profile and thereby also the size and shape of the focal area.
This greatly impacts the scanning strategy when conducting an animal experiment.
3.2.1 Tumor placement
As mentioned in section 2.2.3, the transmitted sound field from an ultrasound
transducer will consist of areas of constructive and destructive interference. The
focal area is the area where the highest pressures and intensities occur. In order
to maximize the radiation force, it would therefore be reasonable to place the
tumor in the focal zone. However, the area of the focal zone is dependent upon
the F-number and wavelength. If the transducer has a high center frequency, or if
it is strongly focused, the focal area will be small. A sub-millimetre focal area can
be hard to detect in microscopy analysis. In order to irradiate an area which is
possible to detect in microscopy analysis, the tumor can be placed in the front or
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in the back of the focal area, where the beam is wider, but has a lower intensity.
It is then important not to place the tumor in destructive interference zones.
3.2.2 Scanning area
When designing an animal trial for treatment purposes, the aim is not necessar-
ily to cure the animal. In an UMDD experiment, it is of higher importance to
verify that one is able to move drug carriers from the capillary flow and into the
interstitium. The tumor vasculature lies in the peripheral parts of the tumor, it is
therefore important to prove that the drug carriers are moved towards the central
tumor region after ultrasonic treatment. If the aim was to cure the animal, the
whole tumor would need to be irradiated by ultrasound waves. However, for the
proof of concept, it is necessary to scan an area which is detectable by microscopy
analysis. As mentioned in the above section, the focal zone is potentially small.
By placing the tumor in front or back of the focal zone, one gains a larger irradi-
ated area, but looses intensity and thereby applied force. An alternative to this
is to scan a wider area by moving the beams. As mention in section 2.3.3, rect-
angular array transducers often provide electronic beam steering in azimuth, and
sometimes also in elevation direction. However, since most commercial therapy
transducers are circular single-element transducers, they must be manually moved
in order to move the beam and scan an area.
Movement of the ultrasound beam also provides opportunities to avoid tissue heat-
ing. If only one spot is treated, heat will accumulate in that area over time. Several
beams in different spots will distribute the heat generation. By clever selection of
a scanning pattern, one can avoid the heat to accumulate in small volumes over
time. A linear scanning pattern will gradually accumulate heat along the scanning
line. However, if one chose a pattern where no points in close proximity to each
other are scanned following each other, the heat generated at one location will
have time to diffuse before an adjacent area is insonified.
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As seen from equations (2.14), the length of the focal zone is larger than the width.
In order to avoid scanning also in the z-direction, one can chose a frequency and
F-number which gives a focal length that covers the tumor in axial direction.
However, attenuation of the wave in tissue will lead to reduced intensities in the
back of the tumor. Axial scanning will also suffer from attenuation losses, and the
generated forces will be smaller in the distal than proximal tumor periphery.
3.2.3 Scanning time
The aim of an experiment to verify the impact of radiation force in UMDD is
to create both as large force as possible, but also as large impulse as possible.
Impulse is the integral of the applied force over time
J =
∫
Fdt (3.6)
If the ECM is thixotropic or requires a force above a certain threshold to move
the particles, the particle velocity can be modelled as
~u = µPos(Fr − F0) (3.7)
where µ is the friction coefficient of the surrounding tissue, Fr is the URF and F0
is the threshold which must be overcome in order to initiate particle movement.
Pos(Fr − F0) is the difference between these forces when the URF is larger than
the threshold. If the ECM is thixotropic, the matrix will be less viscous when a
movement is initiated, and the forces needed to continue the movement might be
smaller than the force needed to initiate it. If one only assumes that a threshold
is needed to be overcome, the length of the particle movement will be
l =
∫
~udt = µ
∫
Pos(Fr − F0)dt (3.8)
This implies that one also aims to maximize the efficient scanning time. The
maximum scanning time is limited by the half life of the nanoparticle drug carriers.
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Over time these carriers will degrade, and in order to reach the desired effect, one
should therefore aim to treat the tumor when a significant fraction of the carriers
still circulate, i.e. within the half life of the nanoparticles. The maximum efficient
scanning time is limited by the duty cycle. If the half life of the particles is Thl,
the maximum efficient scanning time will be
Teff,max = Thl ·DC (3.9)
This is the efficient total scanning time over all scanned areas. If more areas
are scanned by moving the ultrasound beam, the total efficient scanning time per
beam is the total efficient scanning time divided by the number of beams, N .
Teff,beam =
Teff,max
N
(3.10)
It is important to notice that with such a scanning pattern the applied force is the
same per area, but the impulse per area will be reduced.
Another aspect to consider is the pulse length. Ideally one wants to apply a force
to the same particle several times. In order to do so, one must ensure that the
pulse repetition frequency is high enough, so that the particle will not move out
of the beam between two pulses. The particle movement follows the blood flow,
which for tumor capillaries is approximately 40 − 350 µm/s [34]. The distance a
particle moves between two following pulses is
d = vbTr (3.11)
where vb is the blood velocity and Tr the pulse repetition time. This is given by
Tr =
Tp
DC
(3.12)
where Tp is the pulse length. If the aim is to hit the same nanoparticle at least
twice, the maximum distance it can move between two pulses is the distance
corresponding to the smallest beam width. The beam is most narrow in the focal
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zone, i.e
d = vbTr = vb
Tp
DC
≤ Df = λF# (3.13)
This means that the pulse length is limited by
Tp ≤ λF#DC
vb,max
(3.14)
A longer pulse length enables the transducer to operate in a narrower frequency
band. The piezoelectric elements will then vibrate close to their resonance fre-
quency, which in most cases lead to higher efficiency. On the other hand, it is
shown that short pulses and high pulse repetition frequency(PRF) creates larger
streaming of microbubbles due to URF than long pulses and low PRF [35]. This
might be due to resonance in the bubbles, and it is not known whether this effect
can be observed with nanoparticles. If this is valid also for nanoparticles, deter-
mining the pulse length can be a trade-off between transducer bandwidth and
generated particle streaming.
3.2.4 Tumor sectioning and analysis
As mentioned in section 3.2.1, the scanned area must be large enough to detect in
microscopy analysis. In order to investigate the results of an in vivo experiment,
confocal microscopy is used to analyse tumor slices. The nanoparticles are labelled
with fluorescent dyes which are detectable in a confocal microscope. By staining
the capillaries in a different color, one is able to detect the amount of drug carriers
which has left the vessels, and how far they have moved. There are two main
strategies to detect this movement:
• The tumor can be sliced horizontally. By knowing where the slices are taken,
one can calculate how many particles which have moved into that depth.
• The tumor can be sliced vertically. Stained blood vessels and particle move-
ment will than be available within the same slice, but only in the areas which
are covered by the ultrasound beam.
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Figure 3.2: Possibilities for tumor sectioning. Horizontal slicing to the left,
vertical slicing to the right. The arrows indicate the direction of the ultrasound
beam.
The two strategies are illustrated in figure 3.2. Both strategies require that one
knows where the tumor is scanned. By only scanning a part of the tumor, the other
parts can be used as control slices. One would assume more signal from particles
in areas which are scanned than those that are not treated by ultrasound.
3.3 Propagation through water
In order to obtain wave distortion and higher frequency components, it is desirable
that the wave first propagates through a medium with low attenuation, like water.
This will cause larger forces as the high frequency components are absorbed when
the wave reaches the tissue. There are several approaches to how this can be
done physically. When deciding on a physical set-up, it is important to keep in
mind that an acoustic coupling between the transducer and the tumor must be
preserved.
In order to ensure good acoustic coupling between the tumor and the transducer,
the easiest way would be to immerse both the tumor and the transducer in wa-
ter. This was done by Eggen et al. [2], as seen in figure 3.3. This experiment
was conducted with transducers with low frequencies and relatively large aper-
tures, so that the entire tumor was covered by the ultrasound beam in the focal
zone. This type of set-up is not necessarily well suited for smaller transducers and
larger frequencies, where mechanical movement of the probe is necessary in order
to insonify the desired parts of the tumor. Mechanical movement of the probe
does not allow for the transducer to be mounted in the bottom of a water tank.
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Figure 3.3: Radiation force experiment with both transducer and tumor im-
mersed in water [2].
Alternatively, one can move the mouse, rather than the transducer, in order to
allow a fixed transducer in the bottom. Another approach can be to mount the
transducer to a scanning robot inside the water tank. However, movement of the
transducer within the water tank may cause air bubbles in the water, which may
lead to reflections of the beam and reduced forces.
Instead of having the transducer at the bottom of the tank and the mouse on the
top, one can have the mouse at the bottom and the transducer at the top. This was
done by Tung et al. [36], where the mouse was carefully placed underneath a water
container as illustrated in figure 3.4. In such a set-up, it is of high importance that
the acoustic coupling between the animal and the transducer is preserved. The
membrane which separates the water and the mouse should have similar acoustic
impedance to water or tissue, in order not to create another reflection interface
where energy is lost. It should also be thin, ideally the thickness should be d = λ
2
n,
where n is an integer, in order to eliminate reflections.
Reflections from the back of the tumor are also important to consider. Bones in
the body are strong reflectors, and so is air. One must therefore carefully select
the angle of insonation and place acoustic absorbers in the back of the tumor.
If there is bone or air behind the tumor, the wave will be totally reflected into
the body, causing a radiation force to act in the opposite direction. The effect
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Figure 3.4: Ultrasound induced cavitation experiment with the mouse placed
underneath the water container [36].
of this force may reduce the effect of the initial radiation force, as it pushes the
nanoparticles back in the opposite direction.
Chapter 4
Simulations
In order to design the best possible ultrasound radiation force experiment, it is im-
portant to be able to simulate the output from different transducers. This chapter
presents different simulations in order to illustrate the output from an Olympus
i8-0518-P-SU single element immersion transducer with 60 mm focal length. Since
nonlinear wave propagation generates higher harmonics for each depth step itera-
tion, a raised cosine low-pass filter is applied to the field in each depth in order to
keep the frequency components of the propagating wave within half the sampling
frequency. This filter removes some small contributions from higher harmonics,
making the simulations conservative regarding the maximum pressure and URF
which is possible to generate.
4.1 Field simulations
As discussed in section 2.2.3, the sound field from an ultrasound transducer can
be focused and diffracted. Diffraction pattern is of interest in URF applications,
since areas of destructive interference will produce zero or very small radiation
forces. Regions of interest should therefore be placed in areas where the sound
field has large intensities.
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Figures 4.1 - 4.3 illustrate the acoustic field resulting from three different apertures.
The beams are all focused in 60 mm and have a center frequency of 5 MHz. The
sound waves travel through 55 mm water, before they reach tissue. The simulation
parameters for the three simulations are listed in table 4.1
Table 4.1: Simulation parameters for field simulations
Simulation parameters
Center frequency 5 MHz
Aperture Circular
Aperture width 10, 19 and 29 mm
Pulse length 1 µs
Focus 60 mm
Water propagation 55 mm
Initial pressure 200 kPa
Figure 4.1 shows the sound field generated by a circular transducer with 10mm
aperture diamter. The corresponding F-number is F# = 6. This is a relatively
large F-number, and the focusing is weak. Two areas of destructive interference
can clearly be seen on the beam axis at z ≈ 15 mm and z ≈ 25 mm.The focal zone
is stretched and wide. It can also be noted that the maximal pressure is relatively
small, due to the weak focusing.
Figure 4.2 shows the acoustic output from a 19 mm wide circular aperture, focused
in 60 mm. From this simulation, one can clearly recognize the shape of the beam
illustrated in figure 2.5. The F-number is F# ≈ 3, and it can be seen that the
focusing results in higher pressures in the focal zone. Areas of destructive interfer-
ence can in this figure also be seen on the beam axis. Due to the lower F-number,
both the length and width of the focal zone are smaller than in the field generated
by a smaller aperture.
Figure 4.3 illustrates a highly focused acoustic field resulting from a transducer
with 29 mm aperture width. The corresponding F-number is F# ≈ 2, which
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Figure 4.1: Beam profile simulated with 10 mm transducer aperture. Center
frequency is 5 MHz and the focus is 60 mm. The wave propagates 55 mm in
water before it reaches the tissue.
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Figure 4.2: Beam profile simulated with 19 mm transducer aperture. Center
frequency is 5 MHz and the focus is 60 mm. The wave propagates 55 mm in
water before it reaches the tissue.
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Figure 4.3: Beam profile simulated with 29 mm transducer aperture. Center
frequency is 5 MHz and the focus is 60 mm. The wave propagates 55 mm in
water before it reaches the tissue.
generates high pressures in a narrow focal zone. The pressures shown in the field
simulations are the peak positive pressures, as they generate the largest intensities
and therefore are of most interest in an ultrasound radiation force context.
4.1.1 Rectangular aperture
Rectangular apertures are common in medical imaging applications. They can
however also be used for treatment purposes. Figure 4.4 and 4.5 show the beam
profiles in azimuth and elevation resulting from a rectangular aperture. The sim-
ulation parameters used in this simulation are given in table 4.2.
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Figure 4.4: Azimuth beam profile simulated with a rectangular aperture.
Center frequency is 5 MHz and the focus is 60 mm. The wave propagates 55 mm
in water before it reaches the tissue.
Table 4.2: Simulation parameters for rectangular aperture
Simulation parameters
Center frequency 5 MHz
Aperture azimuth 15 mm
Aperture elevation 8 mm
Pulse length 1 µs
Focus azimuth 60 mm
Focus elevation 60 mm
Water propagation 55 mm
Initial pressure 200 kPa
Both azimuth and elevation focus is in 60 mm. This corresponds to an F-number
in azimuth of F#,azi = 4 and in elevation F#,elev = 7.5. The different F-numbers
lead to very different beam profiles and pressure distributions in elevation and
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Figure 4.5: Elevation beam profile simulated with rectangular aperture. Cen-
ter frequency is 5 MHz and the focus is 60 mm. The wave propagates 55 mm in
water before it reaches the tissue.
azimuth. The interference pattern is fundamentally different from the circular
apertures simulated in the above section. Due to the rectangular aperture, less
areas of destructive interference are created, and no zero-points can be seen on the
axis. In elevation the rectangular aperture is very weakly focused. This can be
seen in the resulting beam profile, where the focal zone is long and wide. Another
interesting phenomena is the side lobes generated in elevation. Since the beam is
weakly focused, a large amount of the energy is directed in angles different from the
propagating direction. These waves interfere and form side lobes symmetrically
around the beam axis. The weakly focused elevation aperture leads to a more
evenly distributed pressure profile also in azimuth. The energy is not directed
similarly in azimuth and elevation, resulting in less constructive interference and
lower generated pressures.
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4.2 Ultrasound radiation force
Simulation of the URF output is valuable when planning an URF experiment.
Simulation of the generated force on the axis as well as the distribution of force
throughout the region of interest can be helpful in order to choose an appropriate
transducer and design the physical set-up of the experiment.
4.2.1 Frequency dependence
There are two main effects the choice of frequency has on the generated URF.
These are
1. The extinction cross section increases with increasing frequency.
2. The non-linear distortion of the waveform generates higher harmonic fre-
quency components in the focal zone, which lead larger forces.
Since these effects are non-linear, it is interesting to investigate to which extent
URF is dependent upon the center frequency. Figure 4.6 illustrates a simulation of
URF generated on the beam axis with varying center frequency. The parameters
used in the simulation are given in table 4.3.
Table 4.3: Simulation parameters for URF frequency dependency
Simulation parameters
Center frequency Varying
Aperture Circular
Aperture width 29 mm
Pulse length 1 µs
Focus 60 mm
Water propagation 55 mm
Initial pressure 200 kPa
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Figure 4.6: Frequency dependency of ultrasound radiation force distribution
for the parameters given in table 4.3.
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Figure 4.7: Frequency dependency of ultrasound radiation force in focus
(60 mm) for the parameters given in table 4.3.
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As seen from these simulations, the radiation force is at largest for center frequen-
cies of 8− 13 MHz. This is due to the fact that extinction cross section increases
with increasing frequency. From equation (2.36) it can be seen that the frequency
for maximum intensity drops with increasing depth, as the extinction cross section
will reduce the intensity. For frequencies up to ∼ 13 MHz, the increasing extinc-
tion cross section produces a larger force. For frequencies larger than ∼ 13 MHz,
the increasing extinction cross section attenuates so much of the wave intensity,
that the product results in a decreasing force for increasing frequencies.
4.2.2 Effect of non-linearities
As seen from figures 2.2 and 2.3 in chapter 2, non-linearities greatly impact the
waveform and frequency components of the propagating wave, and thereby also the
generated peak pressures. URF is proportional both to extinction cross section and
intensity and is therefore highly dependent on the non-linear waveform. Energy
pumped into higher harmonics will generate a larger extinction cross section, which
contributes to a larger generated force.
Figures 4.8 - 4.11 show simulations of ultrasound radiation force generated by
simulation parameters in table 4.4. Figures 4.8 and 4.9 are generated by linear
simulations, while figures 4.10 and 4.11 are generated by non-linear simulations.
Comparing the linear and the non-linear simulations, one can clearly see that the
amplitude of the generated force is approximately four times larger for the non-
linear simulation. It is also worth noting that the force field looks different with
linear and non-linear simulation. This is due to diffraction of the higher harmonic
components in the non-linear simulation. Higher harmonics generate narrower
beamwidths and reduced side-lobe levels in the field [37, 38]. The non-linear field
is more directed behind the focal point, as higher frequencies are attenuated and
more energy is lost in the propagation. This can also be seen from the axial
distribution of the force.
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Figure 4.9 shows the radiation force generated on the beam axis with a linear
simulation. As water is assumed to have no attenuation, no force is generated
before the wave reaches the tissue. However, when the wave reaches tissue, the
generated force is approximately −1.5 dB lower than the maximum force. The
−3 dB limit is approximately in 63 mm. For the non-linear case, as illustrated
in figure 4.11, the force generated at the interface between water and tissue is
−6.9 dB lower than the maximum force. The −3 dB width is approximately from
57 to 62 mm. This shows that a larger force is distributed in a smaller area when
non-linear propagation is assumed.
Table 4.4: Simulation parameters for URF simulation
Simulation parameters
Center frequency 5 MHz
Aperture Circular
Aperture width 29 mm
Pulse length 1 µs
Focus 60 mm
Water propagation 55 mm
Initial pressure 200 kPa
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Figure 4.8: Radiation force distribution generated by a linear simulation of
the propagating wave. The aperture is 29 mm, center frequency is 5 MHz and
the focus is in 60 mm.
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Figure 4.9: Radiation force on the beam axis generated by a linear simulation
of the propagating wave. The aperture is 29 mm, center frequency is 5 MHz and
the focus is in 60 mm.
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Figure 4.10: Radiation force distribution generated by a non-linear simulation
of the propagating wave. The aperture is 29 mm, center frequency is 5 MHz and
the focus is in 60 mm.
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Figure 4.11: Radiation force on the beam axis generated by a non-linear
simulation of the propagating wave. The aperture is 29 mm, center frequency is
5 MHz and the focus is in 60 mm.
Chapter 5
In vivo experiment
An in vivo experiment was conducted in cooperation with Professor Catherina
deLange Davies’ group at the Department of Physics. Human prostate cancer
xenografts were implanted in the back right leg of 28 nude mice. 23 of these
mice developed tumors larger than 6 mm in diameter, and could be used in the
experiment.
5.1 Transducer
The transducer used in the experiment was an Olympus i8-0518-P-SU single ele-
ment immersion transducer, with center frequency of 5 MHz. This transducer is
from the Olympus HARISONIC ”P” series, which is a series of transducers in-
tended to provide high output and penetrating power [33]. The aperture diameter
is 29 mm and it is focused in 60 mm. Initially, four different transducers were or-
dered, in order to chose the best one based on the characterization measurements.
Two of these had a center frequency of 10 MHz, and two had a center frequency
of 5 MHz. However, due to internal miscommunication within Olympus, the i8-
0518-P-SU transducer was the only one which was focused and therefore suitable
for the experiment.
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Watertank measurements determined the efficiency of the transducer to be η ≈
6−10 %. Olympus recommends the electrical input power to be limited to 125 mW.
However, temperature and impedance measurements indicated that the transducer
could be driven at an electrical input power of Pel = 2 W when immersed in
water, without changes in the input impedance or significant heat generation.
The transducer specifications are listed in table 5.1
Table 5.1: Transducer specifications for in vivo experiment
Transducer specifications
Center frequency 5 MHz
Aperture Circular
Aperture size 29 mm
Focus 60 mm
Efficiency 6-10 %
Pel,max 2 W
|Zel| 48 Ω
φel 21
◦
The transducer F-number is F# ≈ 2, which gives the corresponding focal length
and width;
Df ≈ 0.6 mm and Lf ≈ 5 mm (5.1)
Since most tumors were wider than they were tall, it was decided not to scan in
the z-direction, as the focal length covers almost the entire tumor.
The available power amplifier was a ENI 2100L 55 dB amplifier (ENI, Rochester,
NY, USA), however, its behaviour was not entirely linear. A 1 V peak to peak input
voltage was amplified to 360 V by the amplifier, but gradually reduced to 340 V
during 15-20 minutes of scanning. With respect to the highest generated peak to
peak voltage, the maximal duty cycle was calculated to be DCmax = 0.15%. The
pulse length was chosen to be 5 cycles, i.e. 1 µs. This gave a pulse repetition time
of Tr = 666 µs, and the corresponding PRF is 1.5 kHz.
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5.2 Practical set-up
In order to create a large enough scanning area to be detected in a microscope,
a 3 by 3 point scanning pattern in the lateral plane was decided, as illustrated
in figure 5.1. The distance between each point in the pattern corresponds to
the focal width, i.e. 0.6 mm. The robot which was used did not allow for a
more sophisticated scanning pattern. Therefore, a test scan was done in a piece
of chicken meat with a thermocouple to monitor any temperature change before
the in vivo experiment was conducted. The thermocouple did not record any
significant changes in temperature, and it was therefore assumed that a linear
scanning strategy would not lead to any significant heat generation in the mice.
Figure 5.1: Scanning pattern for in vivo experiment
5.2.1 Experiment groups
The nanoparticles used in the experiment were Silica particles with a diameter of
approximately 70 nm. The particle half life in mice was measured to be approxi-
mately two hours. The purpose of the experiment was to investigate two different
effects:
1. Is URF able to enhance transport of particles through the capillary walls in
solid tumors?
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2. Is URF able to push particles through the ECM and into central parts of
the tumor?
In order to investigate these effects, the mice were divided into two groups:
1. In order to investigate whether URF can enhance transport across the cap-
illary walls, the first group would get ultrasound treatment directly after
injection of nanoparticles in the blood. The scan would last for one hour,
to ensure that a large amount of the particles was still circulating when the
treatment was conducted.
2. To investigate the effects of URF on particle movement through the ECM,
the particles were allowed to circulate for four hours before the treatment was
conducted. The amount of particles in the blood would then be small, and
one could look at the effects on the particles which had passed the capillary
walls due to convection.
Another research question interesting to investigate, was whether or not the ECM
has thixotropic properties, and whether force or impulse is of most importance. In
order to investigate this, each of the two groups were divided into two subgroups:
1. The first group was exposed to ultrasound generated with the maximum
voltage available.
2. The second group was exposed to ultrasound generated with approximately
half of the voltage in group one, but the same power.
In addition to these four groups, two control groups were used. These groups were
not exposed to ultrasound. The first control group got nanoparticles which were
allowed to circulate for one hour and fifteen minutes. The other control group got
nanoparticles which were allowed to circulate for four hours. The number of mice
in the control groups was limited, but the actual amount of control mice is larger.
This is due to the fact that only a small volume of the tumors are insonified, and
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the rest of the tumor can then serve as control slices. In that way, the mouse in
the insonified groups also serve as an internal control. The parameters for each
group is given in table 5.2.
Table 5.2: Groups in the in vivo experiment. The number of mice in the
control groups is limited due to the use of non-insonified tumor areas as control
slices in the groups which are exposed to ultrasound.
Group Group 1 Group 2 Group 3 Group 4 Group 5 Group 6
#mice 2 5 5 5 5 1
NP circula-
tion time
4 hours 15 min 4 hours 4 hours 15 min 1h15min
Voltage - 340 V 340 V 160 V 160 V -
Input power - 2 W 2 W 2 W 2 W -
Duty cycle - 0.15 % 0.15 % 0.6 % 0.6 % -
Pulse length - 1 µs 1µs 1µs 1µs -
PRF - 1.5 kHz 1.5 kHz 6 kHz 6 kHz -
Remark control - - - - control
5.2.2 Physical set-up
Since a 3 by 3 scanning pattern was used, the transducer had to be able to move in
order to scan multiple points. It was therefore concluded that it would be easiest
with the water bath on top of the mouse, with some space for the transducer to
be moved. A transducer holder was produced and mounted to a stepping robot.
The water bath was created by attaching a transparent plastic bag to a circular
metal ring so that it was shaped like a cone when it was filled with water. This
setup is illustrated in figures 5.2 - 5.4.
The tumor was placed underneath the tip of the water bath cone, to ensure that
the transducer was directed towards the tumor. In order to ensure good acoustic
coupling, the tumor was covered with ultrasound gel both from above and under-
neath. The mouse was resting on a surgical mat on top of a heating mat, to keep
Chapter 5. In vivo experiment 54
Figure 5.2: Water bath and transducer position in the in vivo experiment.
The water bath is a cone shaped transparent plastic bag, and the transducer is
directed towards the tip of the cone.
Figure 5.3: Positioning of the mouse in the in vivo experiment. The tumor is
placed underneath the tip of the water bath cone, to ensure that the transducer
is directed towards the tumor. The tumor is covered with ultrasound gel in
order to ensure good acoustic coupling.
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Figure 5.4: Entire set-up with stepping motor for the in vivo experiment. The
water bath is mounted to a separate holder.
the body temperature around 37 ◦C. Underneath the heating mat, an acoustic ab-
sorber was placed in a water bath, in order to avoid reflections which potentially
could cause forces acting in the opposite direction.
After treatment, the mouse was euthanized, and the tumor was removed and
mounted to a cork plate and frozen. The tumor was mounted to the plate so that
sectioning can be done vertically, as illustrated in fig 3.2.

Chapter 6
Discussion
Quality assurance has high importance when an animal experiment should be
designed and conducted. Ethical questions rise immediately once animal trials are
used to investigate and verify treatment methods. The aim is therefore to design
reproducible experiments with as few unknown parameters as possible. This is
discussed in the following chapter for an ultrasound radiation force experiment in
mice.
6.1 Transducer selection
As mentioned in section 2.3, high intensity ultrasound treatment transducers need
to have high efficiency, and be able to produce large acoustic output power. From
figure 3.1, the parameters which are given by the transducer are
1. The efficiency, η
2. The maximal electrical input power, Pel,max
3. The electrical impedance, Zel
All these parameters determine the possible acoustic output power the transducer
can generate, and thereby also the force and impulse which are possible to achieve.
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Selection of the right transducer therefore greatly impacts the outcome of an ul-
trasound radiation force experiment. However, only one of the above listed pa-
rameters is provided by most manufacturers. The maximum tolerated input power
is normally provided in the technical notes from transducer manufacturers. This
value is, however, set conservatively low, and is the power limit when the trans-
ducer is exited into air, which generates large reflections at the transducer surface.
For an ultrasound radiation force set-up where the transducer is loaded with wa-
ter, it will most likely tolerate a larger input power than the maximum given by
the manufacturer. This means that one in practice should investigate how much
power the transducer can tolerate, if the maximum limit set by the manufacturer
is low.
The efficiency is in most cases not available from the manufacturer. This param-
eter must therefore also be determined when a transducer is available. Efficiency
measurements can be done with hydrophone in a water tank. For a given elec-
trical input power, the generated acoustic output power can be measured by the
hydrophone. Based on this, the efficiency can be calculated from equation (2.39).
Electrical impedance might be estimated by the manufacturer, but it must be
determined accurately by impedancemeter measurements. Some manufacturers
claim to tune all transducers to a given impedance, however, accurate measure-
ments are rarely provided. As most voltage generators have 50 Ω electrical impedance,
the transducer should have an electrical impedance as close as possible to this, with
a small phase angle.
In sum, this means that one has to chose a transducer based on more or less
unknown parameters. There are, however, possibilities to make qualified estimates
of the transducer performance, based on the estimates and descriptions available
from the manufacturers. Among others, the intended purpose of the transducer
will be described. Therapy transducers will in general have larger efficiency and
possibility to generate larger acoustic outputs than imaging transducers. The
pulse form and bandwidth are also parameters which are available. Narrowband
transducers do often have higher efficiency than broadband transducers.
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6.1.1 Frequency
As seen from the simulations in section 4.2.1, the URF is at largest for frequencies
between ∼ 8 to 13 MHz. In order to gain the highest forces, one should therefore
choose a transducer with a center frequency within that frequency band. A nar-
rowband transducer will in most cases give the largest efficiency. In order to cover
an area as large as possible, it might be clever to chose a transducer with center
frequency around 8 MHz rather than 13 MHz. It is important to bear in mind that
animal experiments are conducted to design treatment strategies which later can
be applied in humans. One must therefore strive to choose equipment which has
potential also in a clinical setting.
As mentioned in section 5.1, four different transducers were ordered in order to
choose the best one for the in vivo experiment. Initially, the idea was to explore
the results in vivo with a 10 MHz transducer, as one would expect this to create the
largest forces. The 5 MHz transducers were ordered in case the 10 MHz transducers
showed poor performance, or alternatively investigate the effect of two different
frequencies and compare this to the simulations. It will however be interesting
to investigate the results from the 5 MHz transducer. If this transducer is able
to generate large enough forces to move the particles through the ECM, larger
frequencies might not be needed. In order to investigate this, the mechanical
properties of the ECM in tumors should be studied. An estimate of how large
forces which are needed to move particles within the ECM would be valuable in
order to optimize the selection of transducer center frequency.
6.1.2 Aperture
Ideally, one could imagine a combined treatment and imaging system, which pro-
vides electronically beam steering in both azimuth and elevation. The imaging
system could then be used to position the tumor correct within the sound field.
However, one must overcome several technological barriers before such a system is
commercially available. A rectangular aperture provides a beam profile with less
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destructive interference than a circular aperture does. In that way, a rectangu-
lar aperture is more convenient with respect to tumor placement within the sound
field. However, commercial transducers which are designed for high intensity ultra-
sound purposes, are mostly circular single element apertures. These transducers
are able to generate large forces, but since a single element only is capable of
pulse-echo measurements, positioning the transducer accurately above the tumor
is a challenge. A pulse-echo measurement is only capable of determining the time
from one echo to the next, and thereby the distance to the scatterer. It is however
not possible to know exactly where the wave is reflected, and therefore difficult to
be sure that the targeted area lies within the sound field.
6.2 Tumor placement
Placement of the tumor within the sound field is a question which rises in particular
when an UMDD scheme is introduced to the clinic. For in vivo experiments in
mice, the area which needs to be insonified is so small that the tumor can be
placed in a narrow focal zone. However, when larger tumors in humans should
be treated, a larger area must be covered within the half life of the drug carrying
particles. This implies that the sound field must cover a larger area of the tumor
and that the transducer must have high efficiency and tolerate large duty cycles.
For an ultrasound radiation force experiment in mice, the area which must be
covered is small, and placing the tumor within the focal zone will generate the
largest forces. There are, however, very little knowledge about how large force
is needed to apply in order to be able to move the particles. One can therefore
imagine that this could be investigated further in future in vivo experiments. If
smaller forces also are sufficient to push the particles across the capillary walls
and through the interstitium, the tumor could advantageously be placed in front
of the focal area.
In the conducted in vivo experiment, the tumor was placed within the focal zone.
The transducer was exited with two different voltages, but the same total power
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for the different groups in the experiment (see table 5.2). The lower voltage gener-
ates lower intensities in the focal zone. The results from this experiment must be
analysed in order to investigate whether the variation in intensities makes a differ-
ence or not. If one is able to detect particle movement also in the groups that got
lower intensity treatment, this can be an indication of the importance of maximal
impulse rather than maximal force. However, if particle movement is larger in the
groups with maximal intensity, this can be an indication of thixotropic properties
of the ECM, which create the need for large forces in order to be able to move
particles to central tumor areas.
6.3 Practical set-up
As the focal zone was narrow, a scanning strategy was needed in the in vivo
experiment. It was therefore concluded that a water bath where the transducer
could move on top of the mouse was the best solution. The water bath was made
from a transparent plastic bag and a metal ring. This was not a robust solution.
The metal ring was approximately 14 cm in diameter, and it was difficult to access
the transducer surface to remove air bubbles. Positioning the transducer above
the tumor was also not a straight forward process. The plastic bag slided slightly
on the metal ring, so that the transducer needed to be repositioned between every
scan. For reproducibility and quality assurance, a more robust set-up should be
constructed.
The mats on which the mouse rests, are also sources of unpredictable behaviour.
As mentioned in the previous chapter, the tumor was covered in ultrasound gel
both from above and below. However, it was hard to create good acoustic coupling
between the gel on top of the surgical mat and the acoustic absorber below the
heating mat. The weight of a mouse is around 15 to 20 g, which creates a minimal
pressure against the surface of the surgical mat. This allows for air bubbles and
cavities to form between the two mats in front of the acoustic absorber. When air
was present, this could clearly be seen from pulse-echo measurements as a strong
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reflector. Future experiments should try to minimize this problem, in order to
ensure that the majority of the sound waves propagate in the same direction.
An important aspect is that tumors in the human body are not always close to
the skin and easily accessible. Tumors can often be found in internal organs in the
body, like prostate, liver and pancreas. This is a challenge in UMDD. As seen from
figure 2.4, the sound waves are strongly attenuated as they propagate through
tissue. Nonlinear effects accumulate in mediums with low attenuation, but are
attenuated in absorbing mediums. One must be able to generate high intensities
as well as higher harmonic components in order to generate a significant radiation
force. This is one of the main challenges in developing an UMDD scheme which
is suitable for clinical use.
Chapter 7
Conclusions
Previous in vivo experiments have shown promising results for the use of ultra-
sound radiation force to enhance transport of macromolecules across the vessel
walls in solid tumors. However, the results from the conducted experiment must
be analysed in order to gain new knowledge about the mechanisms of ultrasound
mediated drug delivery. There are still technological and biological barriers to
overcome before ultrasound radiation force can be used in the clinic, and further
in vivo experiments must be conducted before one can start clinical trials. The
importance of increased therapeutic indices for chemotherapeutic drugs is clear,
and ultrasound radiation force shows great potential in enhancing this. With de-
velopment of high-performance ultrasound transducers and scanners, ultrasound
mediated drug delivery can be a treatment method for the future.
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